{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:49:22Z","timestamp":1771480162578,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.trsl.2006.03.003","type":"journal-article","created":{"date-parts":[[2006,8,8]],"date-time":"2006-08-08T16:46:58Z","timestamp":1155055618000},"page":"63-71","source":"Crossref","is-referenced-by-count":8,"title":["Desferri-Exochelin, a lipid-soluble, hexadentate iron chelator, effectively removes tissue iron"],"prefix":"10.1016","volume":"148","author":[{"given":"Yvonne K.","family":"Hodges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus A.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence D.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2006.03.003_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1196\/annals.1345.006","article-title":"Survival and complications in thalassemia","volume":"1054","author":"Borgna-Pignatti","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trsl.2006.03.003_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.moh.0000152631.63469.07","article-title":"New developments in iron chelators","volume":"12","author":"Cunningham","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.trsl.2006.03.003_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1067\/mlc.2003.18","article-title":"Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy","volume":"141","author":"Obejero-Paz","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.trsl.2006.03.003_bib4","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/S0021-9258(17)43139-5","article-title":"Iron-catalyzed hydroxyl formation","volume":"259","author":"Graf","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2006.03.003_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.10348","article-title":"Iron chelators for the treatment of iron overload disease","volume":"73","author":"Chaston","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.trsl.2006.03.003_bib6","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0006-2952(91)90109-I","article-title":"Evidence that desferrioxamine cannot enter cells by passive diffusion","volume":"41","author":"Lloyd","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2006.03.003_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1979.tb01167.x","article-title":"Studies in desferioxamine and ferrioxamine metabolism in normal and iron-loaded subjects","volume":"42","author":"Summers","year":"1979","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trsl.2006.03.003_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM197708252970804","article-title":"Continuous subcutaneous administration of deferoxamine in patients with iron overload","volume":"297","author":"Propper","year":"1977","journal-title":"N Eng J Med"},{"key":"10.1016\/j.trsl.2006.03.003_bib9","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.92.11.5189","article-title":"Iron acquisition by Mycobacterium tuberculosis","volume":"92","author":"Gobin","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2006.03.003_bib10","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1073\/pnas.95.9.5263","article-title":"Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury","volume":"95","author":"Horwitz","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2006.03.003_bib11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbrc.2004.01.101","article-title":"Effect on ribonucleotide reductase of novel lipophilic iron chelators","volume":"315","author":"Hodges","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2006.03.003_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1258\/0023677041958945","article-title":"Experimental animal urine collection","volume":"38","author":"Kurien","year":"2004","journal-title":"Lab Anim"},{"key":"10.1016\/j.trsl.2006.03.003_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0076-6879(88)58067-9","article-title":"Rapid colorimetric micromethod for the quantitation of complexed iron in biological samples","volume":"158","author":"Fish","year":"1988","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.trsl.2006.03.003_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/jmcc.2000.1123","article-title":"Myocardial-directed overexpression of the human \u03b21-adrenergic receptor in transgenic mice","volume":"32","author":"Bisognano","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2006.03.003_bib15","first-page":"H151","article-title":"Progression from hypertrohic to dilated cardiomyopathy in mice that express a mutant myosin transgene","volume":"280","author":"Freeman","year":"2001","journal-title":"Am J Physiol"},{"key":"10.1016\/j.trsl.2006.03.003_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-4274(01)00541-0","article-title":"The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice","volume":"128","author":"Eybl","year":"2002","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.trsl.2006.03.003_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.moh.0000152631.63469.07","article-title":"New developments in iron chelators","volume":"12","author":"Cunningham","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.trsl.2006.03.003_bib18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional overload","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2006.03.003_bib19","first-page":"289","article-title":"Iron-chelating therapy with the new oral agent ICL670 (Exjade\u00ae). Best practice and research","volume":"18","author":"Cappelini","year":"2005","journal-title":"Clin Haematol"},{"key":"10.1016\/j.trsl.2006.03.003_bib20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1084\/jem.183.4.1527","article-title":"Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall","volume":"183","author":"Gobin","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2006.03.003_bib21","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1182\/blood.V88.9.3608.bloodjournal8893608","article-title":"Oxidative stress and antioxidant status in \u03b2-thalassemia major","volume":"88","author":"Livrea","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2006.03.003_bib22","doi-asserted-by":"crossref","first-page":"E1406","DOI":"10.1152\/ajpendo.2000.279.6.E1406","article-title":"Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload","volume":"279","author":"Chen","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.trsl.2006.03.003_bib23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0008-6363(99)00040-1","article-title":"Cardiac function and cytotoxic aldehyde production in a murine model of chronic iron-overload","volume":"43","author":"Bartfay","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2006.03.003_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0741-8329(03)00101-0","article-title":"Iron chelators and iron toxicity","volume":"30","author":"Brittenham","year":"2003","journal-title":"Alcohol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524406002611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524406002611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T06:13:21Z","timestamp":1627712001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524406002611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S1931524406002611"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2006.03.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}